Gaudium Ivf And Women Health Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Gaudium IVF and Women Health Ltd is ₹ 105.75 as of 30 Oct 15:30 . The P/E Ratio of Gaudium IVF and Women Health Ltd changed from 21.2 on March 2026 to 21.2 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Gaudium IVF and Women Health Ltd changed from ₹ 519.04 crore on March 2026 to ₹ 519.04 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Gaudium IVF and Women Health Ltd for the Jun '26 is ₹ 20.5 crore as compare to the Mar '26 revenue of ₹ 30.53 crore. This represent the decline of -32.85% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Gaudium IVF and Women Health Ltd for the Jun '26 is ₹ 3.55 crore as compare to the Mar '26 ebitda of ₹ 12.35 crore. This represent the decline of -71.26% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Gaudium IVF and Women Health Ltd changed from ₹ 3.4 crore to ₹ 1.78 crore over 7 quarters. This represents a CAGR of -30.91% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Gaudium IVF and Women Health Ltd changed from 47.88 % on March 2023 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana.
Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center. Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years.
Gaudium IVF is founded by the Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Gaudium IVF and Women Health Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Gaudium IVF and Women Health Ltd or Transgene Biotek Ltd?

Market cap of Gaudium IVF and Women Health Ltd is 769 Cr while Market cap of Transgene Biotek Ltd is 17 Cr

What are the key factors driving the stock performance of Gaudium IVF and Women Health Ltd and Transgene Biotek Ltd?

The stock performance of Gaudium IVF and Women Health Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gaudium IVF and Women Health Ltd and Transgene Biotek Ltd?

As of October 31, 2026, the Gaudium IVF and Women Health Ltd stock price is INR ₹105.75. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.33.

How do dividend payouts of Gaudium IVF and Women Health Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Gaudium IVF and Women Health Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.